PMP22 and Charcot-Marie-Tooth disease type 1A: Here, we employed the BioID methodology to identify proteins in proximity to PMP22 in our newly established Schwann cell model of CMT1A, with the aim of revealing insights into the molecular processes involved in CMT1A pathogenesis and of identifying potential targets for a therapy design aimed at reducing the aberrant accumulation of PMP22.